Katan Technologies (often referred to as KatanTech) is a global company that specializes in the research, development and marketing of antimicrobial technologies, with focus on eco-responsibility and the ability of its products to prevent microbial mutation or the creation of super-microbes. The company operates in five countries, and its brands are sold and used globally.
The company was founded in 2011 after several years of R&D and business development. The company is headquartered in Mauritius with subsidiaries in Colombia, Panama, Singapore and the U.S.A. The company plans to expand operations to Australia, Central America, Ecuador and New Zealand in 2012.
S.P.A.D.A. (Self-Aligning, Polymeric, Antimicrobial, Durable Array) serves as one of the core antimicrobial technologies of Katan Technologies’ products. S.P.A.D.A. consists of positively charged polymers that molecularly bond to various surfaces. The products are separated into brands that identify the markets into which the S.P.A.D.A. and other Katan technologies are applied.
- Biospada- All-surface antimicrobial protector
- Biospada PLUS- All-surface antimicrobial disinfectant, protector and cleaner
- Verdespada Agro- Antimicrobials for agriculture
- Verdespada Pecuario (for Animals)- Antimicrobials for industrial dairy, aviculture, rabbit breeding and other breeding facilities
- Aplaus- Retail products including hand sanitizers
- Denki- Antimicrobials for high temperature manufacturing processes
- Finfire- A water-based, flame-retardant agent
- ↑ "Reregistration Eligibility Decision for Trimethoxysilyl Quaterny Ammonium Chloride Compounds.", Reregistration for Elligibility Decision (RED) Trimethoxysilyl Quaternary Ammonium Chloride Compounds, United States Environmental Protection Agency, Sept 2007, http://nepis.epa.gov/Exe/ZyNET.exe/P1006LYJ.TXT?ZyActionD=ZyDocument, retrieved 2012-06-20
- ↑ 2.0 2.1 Hutnyak, Tatjana. "Solving the Hospital Acquired Infection Crisis and Microbial Cross-Contamination Problems in Health Care and Related Applications.". Portofino and Associates White Paper: 4-5.
- ↑ Katan Technologies (2012). Retrieved on 2012-06-13.
Hutnyak, Tatjana. "Solving the Hospital Acquired Infection Crisis and Microbial Cross-Contamination Problems in Health Care and Related Applications."Portofino and Associates White Paper (Jan. 2010): 4-5.<https://dl.dropbox.com/u/181924/P%26A%20HAI%20White%20Paper%20Tatjana.pdf>. 
"Reregistration Eligibility Decision for Trimethoxysilyl Quaterny Ammonium Chloride Compounds." National Service Center for Environmental Publications. EPA United States Environmental Protection Agency, Sept. 2007. Web. 20 June 2012. <Document Link>.
| This article uses material from the Wikipedia article Katan Technologies, that was deleted or is being discussed for deletion, which is released under the Creative Commons Attribution-ShareAlike 3.0 Unported License.
| This article uses material from the Wikipedia article , that was deleted or is being discussed for deletion, which is released under the .